Sep
8
Sat
2018
10TH ANNUAL TULANE SYMPOSIUM ON THYROID AND PARATHYROID SURGERY
Sep 8 – Sep 11 all-day
Oct
3
Wed
2018
American Thyroid Association Annual Meeting
Oct 3 – Oct 7 all-day
Oct
4
Thu
2018
VHL International Medical/Research Symposium
Oct 4 – Oct 6 all-day
Oct
21
Sun
2018
ACS Clinical Congress 2018
Oct 21 – Oct 25 all-day

https://www.facs.org/clincon2018

Oct
22
Mon
2018
2018 FAES ENDOCRINOLOGY UPDATE AND REVIEW COURSE AT NIH
Oct 22 – Oct 26 all-day
Mar
23
Sat
2019
ENDO 2019
Mar 23 – Mar 26 all-day
Mar
27
Wed
2019
MEN 2019
Mar 27 – Mar 29 all-day

MEN 2019: 16th International Workshop on Multiple Endocrine Neoplasia

Apr
24
Wed
2019
AACE 28th Annual Scientific & Clinical Congress
Apr 24 – Apr 28 all-day
Sep
12
Thu
2019
Laura Jones: The Poisoning of Jane Stanford
Sep 12 @ 11:30 am – 1:00 pm

Speaker: Laura Jones is the Director of Heritage Services and Special Projects. She is also the  University Archaeologist and an Amy J. Blue award winner.

Sep
30
Fri
2022
24th Annual Fogarty Lecture
Sep 30 @ 4:00 pm – 5:00 pm

Mir Imran has accepted the invitation to be the 24th annual Fogarty guest lecturer.  The date of the event is Friday September 30, 2022 at 4pm.  It will be a hybrid event.

Mir Imran, Chairman & CEO of InCube Labs, is a prolific healthcare innovator and entrepreneur, who has been developing and commercializing breakthrough medical innovations for over 40 years.

Mir began his career as a healthcare entrepreneur in the late 1970’s with his pioneering contributions to the first FDA-approved Implantable Defibrillator (ICD). Since then, Mir has founded more than 20 life sciences companies and two tech companies, 15 of which have seen liquidity events (IPO/Acquisition). His most recent exit, Rani Therapeutics Holdings Inc., went public on Nasdaq in July 2021.

Mir’s inventions have saved the lives of millions of patients, and many have become the standards of care. He has developed innovative therapies for a number of chronic diseases, including, anemia, chronic pain, stroke, diabetes, and several cardiovascular conditions. His recent company, Rani Therapeutics, is revolutionizing the management of chronic diseases, by replacing painful injectable therapies with oral biologics.

Mir holds more than 800 issued & pending US patents. In 2016, QMed named Mir as one of the “Top 50 Medical Inventors of All Time”. Mir is a fellow of the National Academy of Engineering, the National Academy of Inventors and the American Institute of Medical & Biological Engineers. In 2009, Mir was inducted into the Rutgers University Hall of Distinguished Alumni.

Mir is also the co-founder & managing director of InCube Ventures, LP, a medtech/biotech venture capital fund. In addition, Mir serves on the boards of several life science companies, on the advisory board of the Lemelson Foundation, and is a trustee of the UCSC Foundation. He is also an Adjunct Professor of Bioengineering at the University of Pittsburgh and actively supports the promotion and teaching of innovation and entrepreneurship at colleges and universities. As a philanthropist, Mir is passionately supporting education in India and US, especially for underprivileged students.